0
0
1/13/23 at 7:06pm
Organization
Forbes
Author
William A. Haseltine
34 words
0
Comments
An uncommon type of antibody is on the rise after multiple vaccinations or infections. Here we discuss what this could mean.
You are the first to view
https://www.forbes.com/sites/williamhaseltine/2023/01/13/emergence-of-igg4-in-long-term-vaccines-winning-or-losing-the-race/
Create an account
or login to join the discussion